- Nabta Health raises USD 2M pre-Series A, bringing total funding to USD 4.5M, to scale its women-focused healthtech model.
- The new capital will drive expansion of its AI-powered hybrid care system, adding diagnostics, at-home testing, and stronger employer and insurer partnerships.
- Founded in 2017, Nabta aims to reimagine women’s healthcare in emerging markets with accessible, culturally aware, measurable, tech-driven care solutions.
Nabta Health
UAE’s women healthtech, Nabta Health raised USD 2 million in a pre-series A funding round. This brings its total funding to USD 4.5 million.
Looking forward, with the new funding, it aims to accelerate its mission of providing accessible and science-backed healthcare for women. Additionally, it will also support the expansion of its AI-powered hybrid care model across the Middle East and Africa.
It also intends to forge strong partnerships with employers, insurance companies, and healthcare providers. It also aims to introduce new diagnostic options and at-home testing services. This is while simultaneously improving its clinical systems in collaboration with hospitals.
“We are now looking to accelerate our growth so that more women and employers benefit from what we believe is the future of women-centred health: affordable, mobile-first, and engineered for sovereignty,” said Sophie Smith, Founder and CEO of Nabta Health.
Women’s Healthcare
Founded in 2017 by Sophie Smith and Dr. Mussaad Al-Razouki, Nabta Health is a women’s health startup. It aims to build a woman-centric model of healthcare for women in emerging markets. In addition, it offers a combination of online, in clinic and community based care to support women at every stage of life.
“This investment validates our vision – that women’s health in the region can be reimagined through an AI-powered, hybrid care model that meets women where they are, respects cultural context and delivers measurable outcomes,” said Sophie Smith, Founder and CEO of Nabta Health.
If you see something out of place or would like to contribute to this story, check out our Ethics and Policy section.









